Clinical and Laboratory Evaluation of Acute Pericarditis Associated With Antinuclear Antibodies Positivity

dc.contributor.author Dursun, Ali Dogan
dc.contributor.author Saricam, Ersin
dc.contributor.author Erdem, Hakan
dc.contributor.author Sariyildiz, Gulcin Turkmen
dc.contributor.author Ozyer, Esref Umut
dc.contributor.author Bozkurt, Engin
dc.contributor.author Cantekin, Omer Faruk
dc.date.accessioned 2024-07-05T15:26:36Z
dc.date.available 2024-07-05T15:26:36Z
dc.date.issued 2023
dc.description Dursun, Ali Dogan/0000-0001-9056-0025; en_US
dc.description.abstract Background Up to 30% of patients with acute pericarditis develop recurrent pericarditis. Acute pericarditis may be a manifestation of an underlying systemic autoimmune disease. Therefore, we evaluated the characteristics of patients with acute pericarditis according to antinuclear antibodies (ANA) positivity/negativity. Methods Participants with acute pericarditis and negative ANA (n=29), recurrent pericarditis with positive ANA (n=30) and healthy controls (n=11) were examined. The groups were compared using serum parameters (ANA, C-reactive protein, leucocyte count, erythrocyte sedimentation rate, total antioxidant status, nitric oxide (NO), and oxidative stress index (OSI)) and imaging techniques (electrocardiogram, echocardiography, cardiovascular magnetic resonance, and venous Doppler ultrasound). Results In females, acute pericarditis associated with ANA occurred more frequently (p<0.001). ANA-positive acute pericarditis had significantly lower NO and OSI (p<0.05 and p<0.001, respectively) and pericardial inflammation on magnetic resonance. We found a pulmonary embolism in one patient with positive ANA. Slow venous flow (SVF) occurred more often in acute pericarditis associated with ANA than in the ANA-negative group on venous ultrasound (p<0.05). The prevalence of positive ANAs was 1.6 times higher among SVF patients than in controls. Conclusion This study suggests that acute pericarditis associated with ANA is more common in middle-aged females. SVF and lower oxidative stress tests were more common in patients with ANA-associated acute pericarditis. Acute pericarditis associated with ANA could be considered as a hypercoagulable state. Therefore, all newly diagnosed pericarditis patients (especially females) should be checked for ANA positivity. Awareness of this coexistence should be promptly addressed to establish management strategies. en_US
dc.description.sponsorship Medicana International Ankara Hospital; Atilim University School of Medicine en_US
dc.description.sponsorship Medicana International Ankara Hospital and Atilim University School of Medicine supported this work. None of the F<STRONG>UNDING </STRONG>sources influenced the design or production of the article. en_US
dc.identifier.doi 10.2174/1570161121666230131122649
dc.identifier.issn 1570-1611
dc.identifier.issn 1875-6212
dc.identifier.scopus 2-s2.0-85152173545
dc.identifier.uri https://doi.org/10.2174/1570161121666230131122649
dc.identifier.uri https://hdl.handle.net/20.500.14411/2559
dc.language.iso en en_US
dc.publisher Bentham Science Publ Ltd en_US
dc.relation.ispartof Current Vascular Pharmacology
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Acute pericarditis en_US
dc.subject antinuclear antibodies positivity en_US
dc.subject female en_US
dc.subject oxidative stress en_US
dc.subject serum parameters en_US
dc.subject slow venous flow en_US
dc.title Clinical and Laboratory Evaluation of Acute Pericarditis Associated With Antinuclear Antibodies Positivity en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Dursun, Ali Dogan/0000-0001-9056-0025
gdc.author.scopusid 57196954194
gdc.author.scopusid 15840456000
gdc.author.scopusid 58177873400
gdc.author.scopusid 57223187926
gdc.author.scopusid 58177873500
gdc.author.scopusid 7003971982
gdc.author.scopusid 56157187300
gdc.author.wosid Dursun, Ali Dogan/AAH-7617-2019
gdc.author.wosid ERDEM, HAKAN/KMY-8245-2024
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department Atılım University en_US
gdc.description.departmenttemp [Dursun, Ali Dogan] Atilim Univ, Med Sch, Dept Physiol, Ankara, Turkiye; [Saricam, Ersin; Bozkurt, Engin; Ilkay, Erdogan] Medicana Int Ankara Hosp, Dept Cardiol, Ankara, Turkiye; [Erdem, Hakan] Medicana Int Ankara Hosp, Dept Rheumatol, Ankara, Turkiye; [Sariyildiz, Gulcin Turkmen] Medicana Int Ankara Hosp, Dept Gen Surg, Ankara, Turkiye; [Ozyer, Esref Umut] Medicana Int Ankara Hosp, Dept Radiol, Ankara, Turkiye; [Cantekin, Omer Faruk] Gazi Univ, Fac Hlth Sci, Dept Social Work, Ankara, Turkiye en_US
gdc.description.endpage 58 en_US
gdc.description.issue 1 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 51 en_US
gdc.description.volume 21 en_US
gdc.description.wosquality Q3
gdc.identifier.openalex W4318616797
gdc.identifier.pmid 36718967
gdc.identifier.wos WOS:001000364700005
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.diamondjournal false
gdc.oaire.impulse 0.0
gdc.oaire.influence 2.4895952E-9
gdc.oaire.isgreen false
gdc.oaire.keywords Inflammation
gdc.oaire.keywords Leukocyte Count
gdc.oaire.keywords C-Reactive Protein
gdc.oaire.keywords Antibodies, Antinuclear
gdc.oaire.keywords Humans
gdc.oaire.keywords Pericarditis
gdc.oaire.keywords Female
gdc.oaire.keywords Aged
gdc.oaire.popularity 2.0536601E-9
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 03 medical and health sciences
gdc.oaire.sciencefields 0302 clinical medicine
gdc.openalex.collaboration National
gdc.openalex.fwci 0.0
gdc.openalex.normalizedpercentile 0.02
gdc.opencitations.count 0
gdc.plumx.mendeley 1
gdc.plumx.newscount 1
gdc.plumx.scopuscites 0
gdc.scopus.citedcount 0
gdc.virtual.author Sarıçam, Ersin
gdc.virtual.author Sarıyıldız, Gülçin Türkmen
gdc.virtual.author Özyer, Eşref Umut
gdc.virtual.author Dursun, Ali Doğan
gdc.wos.citedcount 0
relation.isAuthorOfPublication 52f1c80b-bfc2-4b0d-9cc1-1bc202293ff7
relation.isAuthorOfPublication de83da41-1b2c-443b-9171-76780fcc3860
relation.isAuthorOfPublication cecbda73-5154-4e91-8a9c-acd95c5da6c6
relation.isAuthorOfPublication f051787a-8f55-4f2e-947e-babc594e7639
relation.isAuthorOfPublication.latestForDiscovery 52f1c80b-bfc2-4b0d-9cc1-1bc202293ff7
relation.isOrgUnitOfPublication 61d96f0d-4282-4348-a82e-27fbd5ad3213
relation.isOrgUnitOfPublication c6d3b3b7-f103-4779-9789-92b2e2420f2d
relation.isOrgUnitOfPublication 1877bd4a-6ea6-43cb-b8ee-28653b95e888
relation.isOrgUnitOfPublication 21b50621-50a1-4421-a981-c17e317aa040
relation.isOrgUnitOfPublication 50be38c5-40c4-4d5f-b8e6-463e9514c6dd
relation.isOrgUnitOfPublication.latestForDiscovery 61d96f0d-4282-4348-a82e-27fbd5ad3213

Files

Collections